Cargando…

Anlotinib-induced acute myocardial infarction: A case report and literature review

Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor, which has been recently approved for the treatment of advanced non-small cell lung cancer in China. One of its mechanisms of action is the inhibition of angiogenesis and it is similar to other anti-angiogenesis drugs, as it has car...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guihong, Chen, Tao, Ding, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444427/
https://www.ncbi.nlm.nih.gov/pubmed/32855689
http://dx.doi.org/10.3892/etm.2020.9041